维普期刊资源整合服务平台（V6.5）

96篇 您的检索式：作者名="Prince HM"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Results from a pivotal, open- label, phase Ⅱ study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy显示文摘	Coiffier B Pro B Prince HM	2012	J Clin Oncol2012，30，6：	1
2	Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma 显示文摘	Piekarz RL Frye R Prince HM	2011	Blood2011，117，22：	1
3	Breast implant- associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients显示文摘	Miranda RN Aladily TN Prince HM	2014	J Clin Oncol2014，32，2：	1
4	Repetitive high-dose topotec an,carboplatin,and paclitaxel with peripheral blood prognitor cell support in pr eviously untreated ovarian cancer:results of a phase Ⅰ study显示文摘	Prince HM Risschin D Quinn M	2001	Gynecol Oncol2001，81，：	1
5	An analysis of clinical trials assessing the efficacy and safety of singleagent thalidomide in patients with relapsed or refractory multiple myeloma显示文摘	Prince HM Schenkel B Mileshkin L	2007	Leuk Lymphoma2007，48，：	1
6	Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure显示文摘	Spencer A Prince HM Roberts AW	2009	J Clin Oncol2009，27，11：	1
7	A multieenter phase H trial of thalidomide and eelecoxib for patients with relapsed and refractory multiple myeloma显示文摘	Prince HM Mileshkin L Roberts A	2005	Clin Cancer Res2005，11，15：	1
8	A muhi- center phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma 显示文摘	PRINCE HM MILESHKIN L ROBERTS A	2005	Clin Cancer Res2005，11，15：	1
9	Treatment -related myelodysplasia following fludarabine combination chemotherapy显示文摘	Tam CS Seymour JF Prince HM	2006	Haematologica2006，91，11：	1
10	Clinical studies of histone deacetylase inhibitors 显示文摘	PRINCE HM BISHTON M J HARRISON SJ	2009	Clin Cancer Res2009，15，12：	1
11	The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study显示文摘	Feyler S Prince HM Pearce R	2007	Bone Marrow Transplant2007，40，5：	1
12	Phase 11 trial of Romidepsin in patients with peripheral T-cell lymphoma显示文摘	Piekarz RL Frye R Prince HM	2011	Blood2011，117，22：	1
13	Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection 显示文摘	Dockrell DH Marriott HM Prince LR	2003	J Immunol2003，171，10：	1
14	Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy 显示文摘	Coiffier B Pro B Prince HM	2012	J Chn Oncol2012，30，6：	1
15	Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma显示文摘	Piekarz RL Frye R Prince HM	2011	Blood2011，117，22：	1
16	Histone deacetylase inhibitors in cancer Therapy显示文摘	Rasheed WK Johnstone RW Prince HM	2007	Exp Opin Investig Drug2007，16，5：	1
17	Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure显示文摘	Spencer A Prince HM Roberts AW	2009	J Clin Oncol2009，27，11：	1
18	Clinical studies of histone deacetylase inhibitors显示文摘	Prince HM Bishton MJ Harrison SJ	2009	Am Assor Cancer2009，15，12：	1
19	An analysis of clinical trials as- sessing the efficacy and safety of single-agent thalidmnide in patients with relapsed or refractory multiple myeloma显示文摘	Prince HM Schenkel B Mileshkin L	2007	Leuk Lymphoma2007，48，1：	1
20	Serum MUCI as a marker of disease status in multiple mycloma patients receiving thalidomide 显示文摘	Mileshkin L Prince HM Seymour JF	2003	Br J Haematol2003，123，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示